Immuno-Oncology Treatment for Colorectal Cancer

     Speaker Dr Dragan Damianovich.

    In this recording of a live webcast event held in July 2020,  Dr Damianovich addressed an audience of health professionals on developments in immuno-oncology in colorectal cancer. Dragan also presented updates from the recent virtual ASCO20 Conference.

    Dr Dragan Damianovich, MD (Zagreb) FRACP, has been a consultant Medical Oncologist at Auckland Hospital since 2006 and at Auckland Oncology since 2008. He is also the expert contributor to Colorectal Oncology Research Review. Dragan is also a member of the Australian Gastrointestinal Trials Group (AGITG), the American Society of Clinical Oncology (ASCO), the European Society of Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC).

     

    Immuno-Oncology Treatment for Urothelial and Renal Cancer

     Speaker Alvin Tan, hosted by Steve Holliday

    In this recording of a live webcast event held in May 2020,  Dr Alvin Tan addressed an audience of NZ healthcare professionals on immuno-oncology in urothelial and renal cancer using case studies to demonstrate recent advances in this fascinating and fast-developing field.

    Alvin is a consultant medical oncologist specialising in genito-urinary cancers at Waikato Hospital and Braemar Hospital in Hamilton.
     

    An Overview of Immunotherapy Treatment options for Urothelial Carcinoma

    Dr Alvin Tan, Medical Oncologist, discusses immunotherapy treatments in the metastatic urothelial setting in NZ.

    Alvin is a consultant medical oncologist specialising in genito-urinary cancers at Waikato Hospital and Braemar Hospital in Hamilton.

    ALK Mutated Lung Cancer: A Rare Subtype of Non-Small Cell Lung Cancer

    Dr Gareth Rivalland, Medical Oncologist, discusses ALK mutated lung cancer. He describes its characteristics, diagnosis and staging, and various treatment options.

     

    Gareth is a Medical Oncologist specialising in thoracic and skin cancers at Auckland City Hospital and Harbour Cancer Centre in Auckland.

    The Future of Immuno-Oncology

     Dr Robert Weinkove, Consultant Haematologist at Wellington Blood and Cancer Centre and Clinical Director at Malaghan Institute of Medical Research discusses the future of immuno-oncology. He outlines new treatment modalities and new combinations of immuno-oncology agents with conventional treatments.
     

    Toxicity of immune checkpoint inhibitors: Immune related side effects

     Dr Rosalie Stephens is a medical oncologist at Auckland Hospital with a special interest in treating melanoma and is a Trustee on the board of Melanoma NZ. In this video podcast Dr Stephens describes some of the side effects produced by the immune checkpoint inhibitor class of treatments.
     

    Immunotherapy for advanced melanoma: clinical outcomes

     Dr Rosalie Stephens is a medical oncologist at Auckland Hospital with a special interest in treating melanoma and is a Trustee on the board of Melanoma NZ. In this video podcast Dr Stephens describes the clinical outcomes achieved with immunotherapy for advanced melanoma.

    Advances in Immuno-Oncology

     Dr Robert Weinkove, Consultant Haematologist at Wellington Blood and Cancer Centre and Clinical Director at Malaghan Institute of Medical Research introduces the topic of immuno-oncology.  He discusses current and emerging classes of cancer immunotherapies and gives an overview of their mechanisms of action, current place in treatment and recognition of adverse effects in primary care.